SEPTEMBER 20246SEPTEMBER - 2024, Volume 02 - Issue 07 (ISSN 2837-3421) Published by ValleyMedia, Inc. Managing EditorGlenn FernandezEditorial StaffVisualizerHenry SmithEmailsales@medtechbusinessreview.comeditor@medtechbusinessreview.commarketing@medtechbusinessreview.comJoshua Parker Merlin WatsonJoe Philip Laura PintoTo subscribe to MedTech Business ReviewVisit www.medtechbusinessreview.com Copyright © 2024 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffGlenn FernandezManaging Editoreditor@medtechbusinessreview.comDrug delivery solutions are transforming as next-generation technologies reshape how medications are administered and monitored. Modern innovations like smart drug delivery systems and sustained-release technologies are leading the way, offering new levels of precision, convenience, and effectiveness.One of the most prominent advancements is the rise of connected drug delivery devices, such as smart inhalers, wearable infusion pumps and auto-injectors. These devices are equipped with sensors that track patient usage, dosage, and adherence, transmitting real-time data to healthcare providers and allowing timely interventions while reducing the need for frequent hospital visits. Sustained-release drug delivery technologies are also transforming patient care. Implantable devices, drug-eluting stents and nanoparticle-based delivery systems allow for the gradual release of medications over an extended period, ensuring a steady therapeutic effect. Implantable drug delivery devices, smart injectors and similar technologies must maintain absolute sterility to prevent infections, particularly when used for extended durations. The stakes are high to ensure these lifesaving devices remain uncontaminated.To address this, new trends in medical device sterilization are emerging that focus on preserving the integrity of these advanced drug delivery systems. Low-temperature sterilization technologies, such as vaporized hydrogen peroxide and ethylene oxide, are being adopted for sensitive materials that cannot withstand high-heat methods. These techniques ensure that devices remain sterile without compromising the functionality of complex drug delivery mechanisms.Driven by these trends, the global drug delivery systems market size is projected to reach $63.38 billion by the end of 2032, growing at a CAGR of 4.0 percent. This edition of the MedTech Business Review offers insights into the latest drug delivery solutions and how companies align with these trends. The magazine features a thought-provoking article from Robert Fink, Vice President of Pharmacy Services at UofL Health. He highlights the importance of building a culture of accountability in healthcare, specifically about controlled substance management and drug diversion prevention. Additionally, an article by Kelley Curtis, PharmD, MBA, Vice President & Chief Pharmacy Officer at St. Luke's Health System, provides a comprehensive overview of the transformative shift in medication access within the healthcare system through the integration of medication lockers, micro-pharmacies and home delivery services.In this edition featuring the top drug delivery solutions providers in 2024, we hope you find the right partner to meet your organization's needs.Let us know your thoughts! The Next Frontiers in Drug Delivery SystemsSarah FernandesEDITORIALGlenn Fernandez
< Page 5 | Page 7 >